CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-01-11 | SAXE JON S Director | Grant or award · Warrant for Common Stock | +20,000 | 20,000 | ||
| 2014-03-19 | DOTSON JERROLD DUANE CFO AND SECRETARY | Other acquisition · Warrant | +100,000 | 100,000 | ||
| 2014-03-19 | Underdown Brian J. Director | Other acquisition · Warrant for Common Stock | +50,000 | 50,000 | ||
| 2014-03-19 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Other acquisition · Warrant | +50,000 | 50,000 | ||
| 2014-03-19 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Other acquisition · Warrant | +150,000 | 150,000 | ||
| 2014-03-19 | SAXE JON S Director | Other acquisition · Warrant | +65,000 | 65,000 | ||
| 2013-12-20 | SAXE JON S Director | Returned to the company · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2013-12-20 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2013-12-20 | SAXE JON S Director | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2013-12-20 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2013-12-20 | SAXE JON S Director | Returned to the company · Stock Option (Right to Buy) | −150,000 | 0 | ||
| 2013-12-20 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2013-12-20 | SAXE JON S Director | Returned to the company · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2013-12-20 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2013-12-20 | SAXE JON S Director | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2013-12-20 | SAXE JON S Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2013-12-20 | SAXE JON S Director | Returned to the company · Warrant for Common Stock | −50,000 | 0 | ||
| 2013-12-20 | SAXE JON S Director | Grant or award · Warrant for Common Stock | +50,000 | 50,000 | ||
| 2013-12-20 | Underdown Brian J. Director | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2013-12-20 | Underdown Brian J. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 20 of 28 · 544 trades